NCT04219254 2026-04-15
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
BioInvent International AB
Phase 1/2 Recruiting
BioInvent International AB
DualityBio Inc.
CytomX Therapeutics
Accession Therapeutics Limited
CytomX Therapeutics
BioCytics, Inc.
Akeso
Kumquat Biosciences Inc.
Grit Biotechnology
Corbus Pharmaceuticals Inc.
Suzhou Abogen Biosciences Co., Ltd.
Egle Therapeutics
Chengdu Baiyu Pharmaceutical Co., Ltd.
Effector Therapeutics
Telix Pharmaceuticals (Innovations) Pty Limited
Grit Biotechnology
TYK Medicines, Inc
Shijiazhuang Yiling Pharmaceutical Co. Ltd